Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News

Semaglutide is the main ingredient in Wegovy and Ozempic. A recent study found it may help reduce the risk of heart attack and stroke in people without diabetes.
Semaglutide is the main ingredient in medications including Wegovy and Ozempic.
ABC News’ Dr. Jennifer Ashton explains a new study in the New England Journal of Medicine that shows a reduction in heart attacks, strokes and death in overweight or obese participants who took semaglutide.

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

Chinese Guideline on the Primary Prevention of Cardiovascular Diseases

Weight-loss drug reduced secondary CV risk in people with overweight or obesity without diabetes

Danielle Belardo, M.D. on Instagram: HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of cardiovascular death, heart attack, stroke, heart failure, AND

Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

Neuralert

Remote Health Solutions

Weight loss drug Wegovy found to lower risk of heart attack, stroke

DeSantis' administration advises against COVID booster for people under 65 - Delta Daily News